CastleArk Alternatives’s MaxLinear MXL Stock Holding History

CastleArk Alternatives’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-245,947	Closed	-$12.1M	–	186
2021 Q3	$12.1M	Buy	+245,947	New	+$11.9M	0.46%	57

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CastleArk Alternatives's MXL Position: Q4 2021 in Review

CastleArk Alternatives sold out of MaxLinear (MXL) in Q4 2021, closing a stake of 245,947 shares — an estimated $12.1M sold.

CastleArk Alternatives first reported a position in MXL in Q3 2021 and held it in 1 quarter. The position peaked at $12.1M in Q3 2021. 290 funds tracked by Wall St. Rank hold MXL as of Q4 2021.

CastleArk Alternatives reported no remaining MaxLinear position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 245,947 MaxLinear shares in Q4 2021, an estimated $12.1M.
CastleArk Alternatives first reported a position in MaxLinear in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's MaxLinear position peaked at $12.1M in Q3 2021.
290 funds tracked by Wall St. Rank held MaxLinear as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.